US4516535A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for neutron-capture tumor therapy
Assignee: Theragenics Corp
•
Filing: 1982-06-22
•
Granted: 1985-05-14
•
Expires: 2002-06-22
Abstract
Abstract A tumorous patient is injected with a compound including an element that accumulates in tumors and that has an isotope which emits an alpha particle in a neutron capture reaction. The patient is positioned in front of a radiation beam that has been filtered to remove most neutrons having energies above 30 KeV and most thermal neutrons, leaving predominantly epithermal neutrons which are moderated to a thermal level by outer layers of tissue and are captured by the incorporated isotope. A radiation beam having neutrons with a wide distribution of energies is filtered with aluminum and sulfur filters, whose cross sections complement each other in providing a beam with energies predominantly in the epithermal range. The filter mass attenuates the gamma radiation. Beams with lower ratios of undesirable gamma radiation to epithermal beam intensity can be attained with filter combinations which include liquid argon. A poor geometry filter of bismuth or lead can also improve the gamma to neutron ratio. Preferably the beam is filtered through a thermal neutron filter as well.
Inventors
- 👤 John L. Russell, Jr.
- 👤 Denise J. Noonan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 00:26
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/10; A61K; A61K41/00; A61K41/009; A61K51/00; A61K51/02; A61K2121/00; A61N2005/1085; A61N2005/109; A61N2005/1092; A61N2005/1098
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
176 words
A method of treating a patient with a malignant tumor comprising administering to the patient a dose of a generally nontoxic compound including an element having an isotope that emits alpha particles when bombarded with neutrons, said compound being administered in a dosage sufficient to accumulate said isotope in the tumor at a concentration of at least about 10 ppm; providing a source that emits neutrons having a broad energy distribution and gamma rays, said source having a port through which a beam of neutrons is emitted, attenuating said beam of neutrons to where said attenuated beam has an energy distribution such that less than about 15 percent of the neutrons in said beam have energies greater than 30 KeV and less than about 30 percent of the neutrons in said beam have energies less than 0.5 eV, said beam providing an incident gamma radiation dose rate within medically acceptable limits, and positioning the patient so that the tumor is in the path of said beam for a time sufficient to effect substantial tumor tissue deterioration.
Claim 2
Independent Claim
176 words
A method of treating a patient with a malignant tumor comprising administering to the patient a dose of a generally nontoxic compound including an element having an isotope that emits alpha particles when bombarded with neutrons, said compound being administered in a dosage sufficient to accumulate said isotope in the tumor at a concentration of at least about 10 ppm; providing a source that emits neutrons having a broad energy distribution and gamma rays, said source having a port through which a beam of neutrons is emitted, attenuating said beam of neutrons to where said attenuated beam has an energy distribution such that less than about 15 percent of the neutrons in said beam have energies greater than 30 KeV and less than about 30 percent of the neutrons in said beam have energies less than 0.5 eV, said beam providing an incident gamma radiation dose rate within medically acceptable limits, and positioning the patient so that the tumor is in the path of said beam for a time sufficient to effect substantial tumor tissue deterioration.
Claim 3
Dependent Claim
26 words
A method according to claim 1 wherein said beam provides a gamma radiation dose rate less than about the biological equivalent of the neutron dose rate.
Claim 4
Independent Claim
141 words
A method of treating a patient with a malignant tumor comprising administering to the patient a compound that selectively accumulates in tumor cells relative to normal cells, said compound including an element having an isotope that emits alpha particles when bombarded with neutrons, said compound being administered in an effective dose whereat the selective accumulation of said isotope in said tumor cells is sufficient to selectively kill tumor cells by alpha particle emission upon bombardment by neutrons, providing a source that emits a beam of neutrons, filtering said neutrons through some combination of an aluminum filter, a sulfur filter and an argon filter, which combination selectively transmits neutrons in the epithermal energy range and attenuates gamma radiation, and positioning the patient so that the tumor is in the path of said filtered beam for a time sufficient to effect tumor destruction.
Claim 5
Independent Claim
141 words
A method of treating a patient with a malignant tumor comprising administering to the patient a compound that selectively accumulates in tumor cells relative to normal cells, said compound including an element having an isotope that emits alpha particles when bombarded with neutrons, said compound being administered in an effective dose whereat the selective accumulation of said isotope in said tumor cells is sufficient to selectively kill tumor cells by alpha particle emission upon bombardment by neutrons, providing a source that emits a beam of neutrons, filtering said neutrons through some combination of an aluminum filter, a sulfur filter and an argon filter, which combination selectively transmits neutrons in the epithermal energy range and attenuates gamma radiation, and positioning the patient so that the tumor is in the path of said filtered beam for a time sufficient to effect tumor destruction.
Claim 6
Dependent Claim
40 words
A method according to claim 3 wherein said combination includes a sulfur filter and an aluminum filter, said sulfur filter has a thickness in the beam direction between about one-half and about two times the thickness of the aluminum filter.
Claim 7
Dependent Claim
27 words
A method according to claim 3 including filtering said beam through sufficient argon effective to reduce the incident gamma radiation dose rate to within medically acceptable limits.
Claim 8
Dependent Claim
41 words
A method according to claim 3 wherein said combination includes a liquid argon filter, the thickness of said liquid argon in the beam direction being between about 1 and about 6 times the combined thicknesses of said aluminum and sulfur filters.
Claim 9
Dependent Claim
15 words
A method according to claim 2 including filtering said beam through a thermal neutron filter.
Claim 10
Dependent Claim
37 words
A method according to claim 7 wherein said thermal neutron filter is effective to reduce the proportion of neutrons having energies below 0.5 eV to below about 30 percent of the total neutrons flux of said beam.
Claim 11
Dependent Claim
34 words
A method according to claim 3 providing a thermal neutron filter between said source and said combination of filters to prevent thermal neutrons from generating gamma radiation within said argon, aluminum and sulfur filters.
Claim 12
Dependent Claim
13 words
A method according to claim 2 using a scattered, indirect beam of neutrons.
Claim 13
Dependent Claim
40 words
A method according to claim 2 wherein said beam is provided by a nuclear reactor core, and a shield formed of material selected from the group consisting of lead and bismuth is positioned adjacent said core to reduce gamma radiation.
References Cited (Backward Citations)
JPS55122720A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-05-13 | 1988-11-12 | 1989-05-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-05-13 | 1992-11-12 | 1993-05-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-05-13 | 1996-11-12 | 1997-05-14 | $7700.00 | Window Closed / Lapsed |